Then, he went blind in his left eye, too. Doctors now say the ... Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy, or NAION — a rare condition that cuts off blood ...

An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy ... with more severe visual field impairment linked to ...

Classically, GCA has a predilection for the short posterior ciliary arteries which supply the optic nerve head, causing sudden painless visual loss with the development of arteritic anterior ischaemic ...

More information: Alan Y. Hsu et al, Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2025.0349 ...

Although only association and not causality can be inferred, this study showed that, among patients who had diabetes, an elevated risk of NAION was associated with semaglutide use compared with ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date. (HealthDay News) — For patients with diabetes, semaglutide use is ...

finding a potential link between the drug and others like it with non-arteritic anterior ischemic optic neuropathy, a condition causing vision loss after a decrease of blood flow to the eyes.

The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy, a condition in which a loss of blood flow to the optic nerve causes sudden and ...

A Maryland man with diabetes is suing Novo Nordisk, alleging that semaglutide (Ozempic, Wegovy) made him blind due to nonarteritic anterior ischemic optic neuropathy. (NBC News) In a large study ...